Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects
- 1 November 1993
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 36 (5) , 467-469
- https://doi.org/10.1111/j.1365-2125.1993.tb00398.x
Abstract
Plasma concentrations of lansoprazole and of its sulphone, sulphide and 5‐hydroxylated metabolites were determined after oral administration of a single 30 mg dose and after 7 days of treatment with a daily 30 mg dose in 12 elderly subjects (mean age 83 years). Results after a single dose were compared with those from a historical control group of 18 young subjects (mean age 23 years). Mean values of AUC after single dose were 2668 ng ml−1 h in the young subjects and 5216 ng ml−1 h in the elderly (P < 0.05). Mean t1/2;z values in young and elderly subjects were 1.4 h and 2.9 h, respectively (P < 0.001). Plasma concentrations of the metabolites were similar in both groups. However, the hydroxylated metabolite of the sulphone was detected only in elderly subjects. Steady state plasma concentrations of lansoprazole were reached after 3 days of dosing with lansoprazole. The accumulation ratio was 1.31 in the elderly subjects.Keywords
This publication has 4 references indexed in Scilit:
- Human gastric acid secretion following repeated doses of AG-1749Alimentary Pharmacology & Therapeutics, 2007
- Determination of lansoprazole and its metabolites in plasma by high-performance liquid chromatography using a loop columnJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- ANTISECRETORY AND ANTIULCER ACTIVITIES OF A NOVEL PROTON PUMP INHIBITOR AG-1749 IN DOGS AND RATS1989
- POSSIBLE MECHANISM FOR THE INHIBITION OF GASTRIC (H+ + K+)- ADENOSINE-TRIPHOSPHATASE BY THE PROTON PUMP INHIBITOR AG-17491989